Radiation Oncology and the Abscopal Effect in TNBC

Radiation Oncology and the Abscopal Effect in...

Up next

Thinking Beyond TROP2 at ESMO 2023

What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991259). The topics and dis ...  Show more

Hereditary Breast Cancer, Genetic Testing, and Therapeutic Implications

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991258). The topics and discussions ...  Show more

Recommended Episodes

S1 Episode 6: Systemic Therapy for Advanced Colorectal Cancer
Medscape InDiscussion: Colorectal Cancer

Join experts Drs Benjamin Schlechter and Diane Saverese as they discuss systemic therapy for advanced colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/988974). The topics and discussions are planned ...  Show more

S2 Episode 5: Adjuvant Chemo in Colorectal Cancer: What's Working Now?
Medscape InDiscussion: Colorectal Cancer

Join Drs Benjamin Schlechter and Jeff Meyerhardt as they discuss the latest breakthroughs in adjuvant chemo for CRC and share their decision-making in real-world scenarios. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ...  Show more

Localized Breast Cancer 2024 UPDATE
Two Onc Docs

This week’s episode  is part 2 of 2024 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status. We are honored to have Dr. Eleonora Teplinsky, a board-certified ...

  Show more

Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update
ASCO Guidelines

An interview with Dr. Lisa Carey from the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, NC, panel member on "Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer: ASCO Guide ...  Show more